PMC:7283670 / 70329-70497 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T252","span":{"begin":88,"end":93},"obj":"Body_part"}],"attributes":[{"id":"A252","pred":"fma_id","subj":"T252","obj":"http://purl.org/sig/ont/fma/fma63083"}],"text":"WJ‐MSCs will be counted and suspended in 25 ml of saline solution containing 0.5% human serum albumin, and will be given to patient intravenously I Primary (3 weeks):"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T157","span":{"begin":88,"end":93},"obj":"Body_part"}],"attributes":[{"id":"A157","pred":"uberon_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"WJ‐MSCs will be counted and suspended in 25 ml of saline solution containing 0.5% human serum albumin, and will be given to patient intravenously I Primary (3 weeks):"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T623","span":{"begin":82,"end":87},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"WJ‐MSCs will be counted and suspended in 25 ml of saline solution containing 0.5% human serum albumin, and will be given to patient intravenously I Primary (3 weeks):"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T249","span":{"begin":57,"end":65},"obj":"Chemical"}],"attributes":[{"id":"A249","pred":"chebi_id","subj":"T249","obj":"http://purl.obolibrary.org/obo/CHEBI_75958"}],"text":"WJ‐MSCs will be counted and suspended in 25 ml of saline solution containing 0.5% human serum albumin, and will be given to patient intravenously I Primary (3 weeks):"}

{"project":"LitCovid-sentences","denotations":[{"id":"T670","span":{"begin":0,"end":168},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"WJ‐MSCs will be counted and suspended in 25 ml of saline solution containing 0.5% human serum albumin, and will be given to patient intravenously I Primary (3 weeks):"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1850","span":{"begin":88,"end":101},"obj":"Gene"},{"id":"1913","span":{"begin":124,"end":131},"obj":"Species"},{"id":"2046","span":{"begin":82,"end":87},"obj":"Species"}],"attributes":[{"id":"A1850","pred":"tao:has_database_id","subj":"1850","obj":"Gene:213"},{"id":"A1913","pred":"tao:has_database_id","subj":"1913","obj":"Tax:9606"},{"id":"A2046","pred":"tao:has_database_id","subj":"2046","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"WJ‐MSCs will be counted and suspended in 25 ml of saline solution containing 0.5% human serum albumin, and will be given to patient intravenously I Primary (3 weeks):"}